Alejandro Falcón

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C Mutation

Adrian G. Sacher, Patricia LoRusso, Manish R. Patel et al. · New England Journal of Medicine · 2023 · 294 citations · Full text

Medicine, Oncology, Pharmacology +16

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Jayesh Desai, Guzmán Alonso, Se Hyun Kim et al. · Nature Medicine · 2023 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17

Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer

Mónica Cejuela Solís, Ana Gil-Torralvo, María Ángeles Castilla et al. · International Journal of Molecular Sciences · 2023 · 67 citations · Full text

Medicine, Oncology, Pharmacology +15

Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study

Alberto Ocaña, Marta Gil-Martín, Silvia Antolín et al. · Breast Cancer Research and Treatment · 2019 · 62 citations

Medicine, Oncology, Pharmacology +12

Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature

Isabel Tena, Garima Gupta, Marcos Tajahuerce et al. · Clinical Medicine Insights Oncology · 2018 · 34 citations · Full text

Medicine, Oncology, Pharmacology +8